Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3-Avadel Pharmaceuticals plc

30th Dec 2025 11:04

RNS Number : 1509N
Bank of America Merrill Lynch
30 December 2025
 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Bank of America Corporation

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

AVADEL PHARMACEUTICALS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

29/12/2025

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

 

 

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

1,822,002

1.871%

551,398

0.566%

(2) Cash-settled derivatives

501,924

0.515%

485,679

0.499%

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.000%

0

0.000%

Total

2,323,926

2.386%

1,037,077

1.065%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Purchase

12

21.5 USD

USD 0.01 common

Purchase

6

21.51 USD

USD 0.01 common

Purchase

41

21.515122 USD

USD 0.01 common

Purchase

6

21.52 USD

USD 0.01 common

Purchase

30

21.53 USD

USD 0.01 common

Purchase

20

21.54 USD

USD 0.01 common

Purchase

108

21.541575 USD

USD 0.01 common

Purchase

2,293

21.544 USD

USD 0.01 common

Purchase

14

21.55 USD

USD 0.01 common

Purchase

346

21.56 USD

USD 0.01 common

Purchase

12

21.565 USD

USD 0.01 common

Purchase

51

21.565099 USD

USD 0.01 common

Purchase

13

21.57 USD

USD 0.01 common

Purchase

2

21.59 USD

 

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Sale

12

21.52 USD

USD 0.01 common

Sale

22

21.523182 USD

USD 0.01 common

Sale

18

21.529445 USD

USD 0.01 common

Sale

240

21.53 USD

USD 0.01 common

Sale

17

21.532353 USD

USD 0.01 common

Sale

22

21.535 USD

USD 0.01 common

Sale

38

21.53579 USD

USD 0.01 common

Sale

17

21.535883 USD

USD 0.01 common

Sale

23

21.536087 USD

USD 0.01 common

Sale

44

21.536364 USD

USD 0.01 common

Sale

15

21.54 USD

USD 0.01 common

Sale

311

21.55 USD

USD 0.01 common

Sale

24

21.550834 USD

USD 0.01 common

Sale

27

21.557038 USD

USD 0.01 common

Sale

50

21.56 USD

USD 0.01 common

Sale

1,409

21.562804 USD

USD 0.01 common

Sale

31

21.563226 USD

USD 0.01 common

Sale

63

21.56381 USD

USD 0.01 common

Sale

65

21.564 USD

USD 0.01 common

Sale

65

21.564154 USD

USD 0.01 common

Sale

33

21.564849 USD

USD 0.01 common

Sale

27

21.565186 USD

USD 0.01 common

Sale

36

21.565278 USD

USD 0.01 common

Sale

35

21.565429 USD

USD 0.01 common

Sale

27

21.565556 USD

USD 0.01 common

Sale

26

21.56577 USD

USD 0.01 common

Sale

74

21.565811 USD

USD 0.01 common

Sale

24

21.565834 USD

USD 0.01 common

Sale

25

21.5664 USD

USD 0.01 common

Sale

37

21.567028 USD

USD 0.01 common

Sale

76

21.567237 USD

USD 0.01 common

Sale

71

21.56817 USD

USD 0.01 common

Sale

70

21.568572 USD

USD 0.01 common

Sale

34

21.569412 USD

USD 0.01 common

Sale

347

21.57 USD

USD 0.01 common

Sale

2

21.59 USD

USD 0.01 common

Sale

446

21.55 USD

USD 0.01 common

Sale

53

21.56 USD

 

 

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

 USD

USD 0.01 common

Swaps

Reducing a short position

806

21.5626 USD

USD 0.01 common

Swaps

Reducing a short position

91

21.5626 USD

USD 0.01 common

Swaps

Increasing a short position

2293

21.5442 USD

USD 0.01 common

Swaps

Reducing a short position

91

21.5498 USD

USD 0.01 common

Swaps

Reducing a short position

19

21.5356 USD

USD 0.01 common

Swaps

Reducing a short position

512

21.5626 USD

USD 0.01 common

Swaps

Reducing a short position

4

21.5398 USD

USD 0.01 common

Swaps

Increasing a short position

108

21.5418 USD

 

 

(c) Stock-settled derivative transactions (including options)

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

No

 

Date of disclosure

30/12/2025

Contact name

Kamil Dziedzic

Telephone number

+353 86 168 4821

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPFBLFXELLBFBL
FTSE 100 Latest
Value9,931.38
Change-9.33